IRIS - Res&Arch Institutional Research Information System - Research & Archive

IORIO, Alfonso
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.953
EU - Europa 9.556
AS - Asia 8.770
SA - Sud America 1.775
AF - Africa 216
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 15
Totale 33.310
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.420
SG - Singapore 4.136
IE - Irlanda 1.766
UA - Ucraina 1.713
RU - Federazione Russa 1.558
BR - Brasile 1.381
HK - Hong Kong 1.337
IT - Italia 1.022
CN - Cina 991
SE - Svezia 868
VN - Vietnam 851
DE - Germania 617
FR - Francia 563
FI - Finlandia 550
CA - Canada 377
GB - Regno Unito 369
KR - Corea 272
IN - India 190
TR - Turchia 190
BD - Bangladesh 147
AR - Argentina 126
IQ - Iraq 100
PL - Polonia 85
UZ - Uzbekistan 83
MX - Messico 79
CH - Svizzera 70
EC - Ecuador 70
AT - Austria 68
CO - Colombia 63
NL - Olanda 59
ID - Indonesia 58
PK - Pakistan 58
ZA - Sudafrica 55
JP - Giappone 52
SA - Arabia Saudita 51
PH - Filippine 41
ES - Italia 36
VE - Venezuela 34
LB - Libano 33
CZ - Repubblica Ceca 32
PY - Paraguay 31
BE - Belgio 30
RO - Romania 30
GR - Grecia 27
MA - Marocco 27
TN - Tunisia 26
CL - Cile 24
AE - Emirati Arabi Uniti 22
KE - Kenya 22
PE - Perù 22
LT - Lituania 21
PT - Portogallo 21
EG - Egitto 20
JO - Giordania 19
MY - Malesia 19
NP - Nepal 19
AU - Australia 17
DO - Repubblica Dominicana 14
DZ - Algeria 14
EU - Europa 14
UY - Uruguay 13
BG - Bulgaria 12
OM - Oman 12
HN - Honduras 11
JM - Giamaica 11
KZ - Kazakistan 11
BO - Bolivia 10
ET - Etiopia 10
AM - Armenia 9
CR - Costa Rica 9
SN - Senegal 8
TW - Taiwan 8
IL - Israele 7
PA - Panama 7
TT - Trinidad e Tobago 7
BH - Bahrain 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
AZ - Azerbaigian 5
KG - Kirghizistan 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
BF - Burkina Faso 4
GE - Georgia 4
HU - Ungheria 4
LU - Lussemburgo 4
PS - Palestinian Territory 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CY - Cipro 3
DK - Danimarca 3
GA - Gabon 3
MN - Mongolia 3
NG - Nigeria 3
NO - Norvegia 3
QA - Qatar 3
RS - Serbia 3
TH - Thailandia 3
AF - Afghanistan, Repubblica islamica di 2
Totale 33.251
Salva come PNG Salva come JPEG
Città #
Singapore 2.754
Dublin 1.764
Chandler 1.692
Hong Kong 1.330
San Mateo 1.102
San Jose 954
Jacksonville 770
Boardman 657
Ashburn 557
Santa Clara 536
Dong Ket 489
Medford 489
Princeton 486
Moscow 468
Lauterbourg 425
Wilmington 369
Altamura 362
Andover 345
Lawrence 283
Perugia 274
Seoul 268
Ottawa 267
Ann Arbor 242
Beijing 163
Ho Chi Minh City 141
New York 140
Des Moines 139
São Paulo 139
Saint Petersburg 130
Los Angeles 127
Piscataway 117
The Dalles 110
Norwalk 108
Izmir 106
Helsinki 94
Shanghai 86
Munich 84
Columbus 68
Hanoi 67
Dallas 60
Rio de Janeiro 57
Falls Church 55
San Paolo di Civitate 54
Warsaw 47
Orem 46
Brooklyn 45
Chicago 43
Baghdad 42
London 42
Tokyo 42
Montreal 39
Frankfurt am Main 38
Woodbridge 38
Chennai 35
Tashkent 35
Nuremberg 34
Turku 33
Belo Horizonte 32
Milan 32
Rome 32
Brasília 31
Johannesburg 31
Redwood City 31
Phoenix 30
Brussels 28
Houston 28
Amelia 25
San Diego 25
Stockholm 25
Atlanta 24
Bogotá 24
Denver 24
Guangzhou 24
San Francisco 24
Amsterdam 22
Dearborn 22
Salvador 22
Boston 21
Bucharest 21
Curitiba 21
Goiânia 21
Guayaquil 21
Istanbul 21
Jeddah 21
Lahore 21
Manchester 21
Redmond 21
Council Bluffs 20
Mexico City 20
Quito 20
Ankara 19
Den Haag 19
Ribeirão Preto 19
Auburn Hills 18
Frankfurt Am Main 18
Nairobi 18
Amman 17
Dhaka 17
Porto Alegre 17
Vienna 17
Totale 20.472
Salva come PNG Salva come JPEG
Nome #
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 190
1286 Prospective consecutive cases of venous thromboembolic diseases at the single Venous thromboembolic Unit of Reggio Emilia 161
Interventions for enhancing medication adherence. 161
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 161
Oral anticoagulant therapy with POC device and remote computer monitoring in the setting of the Italian National Health System (INHS) 151
Serine base exchange enzyme in commercially available porcine lyophilised platelets: different effect of unfractionated and low molecular weight heparins 132
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 131
Acute ketoacidosisin continuous subcutaneous insulin infusion treated Type 1 diabetics impairs the fibrynolytic capacity 129
Establishing the prevalence and prevalence at birth of hemophilia in males a meta-analytic approach using national registries 129
Development and validation of the first treatment satisfaction scale for adult haemophiliacs (Hemo0-SatA) 129
Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial 128
. The role of thrombophilic states in the bleeding tendency of patients with hemophilia 126
Influenza vaccination in patients on long-term anticoagulant therapy. 123
Influenza vaccination in patients on long-term anticoagulant therapy 123
A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation 121
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 119
Sindrome da anticorpi fosfolipidi. Descrizione di un caso clinico con trombosi atriale dx e revisione della casistica di Reggio Emilia 117
A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol. 116
OAT with POC devices and remote computer monitoring in the setting of the Italian NHS: a controlled clinical trial 112
Sustained suppression of hepatitics C by pegylated Interferon (PEG-INF) and Ribavirin in hemophilic patients 111
Thrombophilia and cerebral vein thrombosis 111
Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase. 111
A Predictive Model for the Development of High-Responding Inhibitor In Children with Severe and Moderate Hemophilia A- Results of a Multicenter Cohort Study. 111
Answering relevant research questions via careful observation of clinical practice: a fresh look at the old way forward. 111
LMWH or Ximelagatran versus VKA in the prevention of VTE after major knee surgery: a meta-analysis of randomized controlled trials 110
Audit clinico sull’impiego di plasma fresco congelato (PFC) in Umbria: disegno dello studio e risultati preliminari. 110
Systematic Review of Randomized Controlled Trials of Prophilactic Clotting Factor Concentrate in Hemophilia 109
Low-molecular-weight-heparin for the long term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulant 108
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation. 108
Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism 107
ACP Journal Club. A 9-factor score predicted 2-year risk for bleeding in outpatients with, or at high risk for, atherothrombosis. 107
Audit of the clinical use of fresh-frozen plasma in umbria: study design and results. 107
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors. 107
L’organizzazione del centro per il monitoraggio della terapia anticoagulante orale 106
I disordini congeniti ed acquisiti dell’emostasi e della fibrinolisi 104
Prothrombin 202120A mutation in Behcet’s disease 104
Le trombofilie acquisite 103
Il monitoraggio della terapia anticoagulante orale 103
Effect of dermatan sulphate on activated partial thromboplastin time determined with different reagents 103
Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study. 103
D-DIMER TO PREDICT THROMBOSIS RECURRENCE: COMPARISON OF AGGREGATE DATA AND INDIVIDUAL PATIENT DATA META-ANALYSES. 103
Applied pharmacoeconomics: considerations to drive the choice of a prophylactic antithrombotic regimen 103
Defective indoleamine 2,3-dioxygenase induction is associated with inhibitor development in severe hemophilia a patients carrying f8 gene null mutations. 102
Low-molecular-weight heparin treatment and cancer: pooled analysis of 908 patients treated for three months 101
The good use of plasma. A critical analysis of five international guidelines. 100
D-DIMER TO PREDICT RECURRENCE AFTER A FIRST EPISODE OF UNPROVOKED VENOUS THROMBOEMBOLISM: COMPARISON OF AGGREGATE AND INDIVIDUAL PATIENT DATA META-ANALYSIS 100
Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls 100
Venous thromboembolic disease: clinical reatures of 1282 prospective consecutive cases at angiology unit of Reggio Emilia 99
Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? No 99
Bayesian approach to the assessment of the population-specific risk of inhibitors in hemophilia A patients: a case study 99
A comparison of methods for prediction of pharmacokinetics across factor concentrate switching in hemophilia patients 99
Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS-Hemo project 99
Studio GEMINA: ruolo dei polimorfismi genetici e dell'omocisteinemia nell'infarto del miocardico in giovani-adulti italiani 98
IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA A AND INHIBITORS: THE ITALIAN RETROSPECTIVE-PROSPECTIVE REGISTRY - THE PROFIT STUDY 97
Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders. 97
D-DIMER TO PREDICT THROMBOSIS RECURRENCE AFTER UNPROVOKED VENOUS THROMBOEMBOLISM: EFFECT OF PATIENT- AND D-DIMER-RELATED FACTORS ON RECURRENCE PREDICTION 97
Experimental evidences on the role of silica nanoparticles surface morphology on the loading, release and activity of three proteins 97
APTT evaluation in the presurgery screening: survey of 5000 patients 96
Profilassi della trombosi venosa profonda in neurochirurgia 96
Acute ketoacidosisin continuous subcutaneous insulin infusion treated Type 1 diabetics impairs the fibrynolytic capacity 96
Switching patients in the age of long-acting recombinant products? 96
Ecaps study: multicentric evaluation of cerebral hemorrhage in anticoagulated/antiaggregated patients in the italian emergency rooms 95
Eradicazione del virus C dell'epatite (HCV) dopo terapia combinata con Interferone Pegilato (PEG-INF) e Rivabirina in pazienti emofilici HIV negativi 95
Prolonged antithrombin activity of low-molecular-weight heparins. Clinical implications for the treatment of thromboembolic diseases 95
Impairment of fibrynolytic capacity in experimentally induced ketoacidosis in continuous subcutaneous insulin infusion patients 94
ACP Journal Club. The Wells rule and a primary care rule were useful for ruling out deep venous thrombosis in primary care. 94
A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease 94
Low molecular weight heparin for prevention of venous thromboembolism in elective neurosurgery: a metanalysis 93
Risk factors for venous thromboembolism in patients undergoing elective neurosurgery 93
Critical appraisal of five international guidelines on fresh frozen plasma clinical use. 93
A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews 93
Elderly patients treated with oral anticoagulant: a prospective cohort study 92
Clinical and laboratoristic performance evaluation of three point-of-care devices for INR determination (Coagucheck, ProTime, Harmony) 92
ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C IN HEMOPHILIA PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS 92
Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis. 92
Different mechanism regulate phosphatidylserine synthesis in rat cerebral cortex" 92
Clinical audit of the use of fresh frozen plasma in Umbria: study design and results of the pilot phase. 92
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome 92
Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A 92
Terapia anticoagulante orale con l’impiego di tecnologia POC e monitoraggio via web nell’ambito del Sistema Sanitario Nazionale Italiano 91
D-Dimer Testing to Determine the Duration of Anticoagulation Therapy 91
The association between platelet transfusions and mortality in patients with critical illness 91
Gemina study:genetic polymorphysms and myocardial infarction among italian young adults 90
Genima study: genetic polymorphysms and myocardial infarction among italian young adults 90
Prospective assessment of clinical endpoints of vka treatment in a primary care computer assisted management model. 90
Bioequivalence of B-domain deleted and plasma derived FVIII concentrates. 90
GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks 90
Low molecular weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis 89
The effect of influenza vaccination in patients on long-term oral anticoagulant therapy 89
High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C 89
RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS 89
HAEMOPHILIA MANAGEMENT THROUGH AN INTER-REGIONAL NETWORK IN MIDDLE ITALY 89
The association between venous thromboembolism and physical inactivity in everyday life 89
Mortality and causes of death in Italian persons with haemophilia, 1990-2007 89
Impact of Thrombophilia on Risk of Arterial Ischemic Stroke or Cerebral Sinovenous Thrombosis in Neonates and Children: A Systematic Review and Meta-Analysis of Observational Studies 89
ANTITHROMBOTIC PROPHYLAXIS IN ELDERLY PATIENTS ATRIAL FIBRILLATION ADMITTED TO INTERNAL MEDICINE WARDS IN ITALY: ADHERENCE TO GUIDELINES 89
Pharmacokinetics of plasma-derived vs. recombinant FVIII concentrates: a comparative study. 89
Pharmacoeconomic evaluation of the management of oral anticoagulant treatment with point-of-care devices in the Italian national health care system 88
Heparin reduces venous thromboembolism in neurosurgery but increases the risk of bleeding. (Iorio A, Agnelli G. Low molecular weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a metanalysis. Arch Intern Med. 2000;160:2327-2332) 88
Factor V Leiden and G20210A prothrombin allele are not associated with thrombosis in Behcet’s disease 88
Totale 10.439
Salva come PNG Salva come JPEG
Categoria #
all - tutte 164.229
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.229
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.740 51 742 92 140 123 36 64 1.372 34 25 445 616
2022/20235.912 541 887 95 415 472 660 8 302 2.251 10 193 78
2023/20242.084 157 229 108 36 36 14 507 125 211 82 238 341
2024/20255.072 20 621 63 140 714 106 88 419 1.145 344 1.009 403
2025/202610.285 786 573 628 1.433 1.025 1.040 1.961 581 1.029 901 242 86
2026/202788 88 0 0 0 0 0 0 0 0 0 0 0
Totale 34.016